Skip to the page

Data / Drug companies / Sagent Pharmaceuticals

Sagent Pharmaceuticals: 213 products in the FDA NDC directory, labeler code 25021

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sagent Pharmaceuticals (labeler code 25021) lists 213 products in the FDA National Drug Code Directory, covering 127 finished drugs by generic name. By type: 213 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 16, 2026.

The request: Watch Sagent Pharmaceuticals (FDA labeler code 25021): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
25021
Products in commercial distribution
213
Packages
299
Finished drugs by generic name
127
Prescription products
213
Over the counter products
0
Controlled substance products
Schedule II 1, Schedule III 3, Schedule IV 4, Schedule V 1
Flagged as original packager
183 of 183 products that carry the flag
Started marketing in the last 12 months
15
Products with a marketing end date set
3
Earliest marketing start
March 24, 2008
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)20596.2%
New drug applications (NDA)83.8%

Products by type

TypeProductsShare
Prescription drugs213100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Heparin sodium823
Vancomycin hydrochloride739
Leucovorin calcium518
Baclofen465
Famotidine4138
Ropivacaine hydrochloride320
Zoledronic acid318
Cefoxitin34
Ampicillin and sulbactam34
Mitomycin314
Midazolam hydrochloride319
Cyclophosphamide322
Levothyroxine sodium anhydrous36
Ketamine hydrochloride311
Daptomycin325
Tranexamic acid339
Levetiracetam387
Haloperidol decanoate316
Ceftazidime33
Ceftriaxone27
Ciprofloxacin241
Penicillin g potassium28
Cytarabine25
Doxorubicin hydrochloride220
Adenosine215
Procainamide hydrochloride210
Fulvestrant221
Ampicillin210
Azithromycin monohydrate27
Caspofungin acetate27
Desmopressin acetate227
Caffeine citrate28
Methocarbamol267
Methylprednisolone acetate210
Meropenem217
Fluconazole248
Micafungin sodium24
Ertapenem sodium211
Arsenic trioxide221
Chlorothiazide sodium25
Gemcitabine hydrochloride26
Vecuronium bromide210
Acetylcysteine215
Cefepime hydrochloride24
Furosemide263
Timolol maleate220
Cefuroxime sodium21
Pemetrexed disodium214
Esmolol hydrochloride212
Dexmedetomidine hydrochloride221
Ketorolac tromethamine269
Dexamethasone sodium phosphate225
Docetaxel anhydrous25
Enoxaparin sodium218
Latanoprost115
Dorzolamide hydrochloride111
Ganciclovir sodium15
Foscarnet sodium110
Thiotepa18
Labetalol hydrochloride143
Diltiazem hydrochloride155
Isoproterenol hydrochloride113
Propofol115
Indigotindisulfonate sodium12
Travoprost14
Ampicillin sodium111
Phenylephrine hydrochloride177
Magnesium sulfate heptahydrate120
Indocyanine green14
Polymyxin b sulfate16
Decitabine118
Verapamil hydrochloride146
Diphenhydramine hydrochloride1127
Rocuronium bromide125
Ondansetron hydrochloride148
Lacosamide157
Fluphenazine decanoate19
Levofloxacin142
Fluorouracil121
Melphalan hydrochloride114
Nelarabine113
Carboprost tromethamine122
Palonosetron hydrochloride111
Prochlorperazine edisylate116
Triamcinolone acetonide177
Lincomycin hydrochloride16
Nafcillin sodium18
Busulfan18
Cisplatin111
Paclitaxel120
Bortezomib126
Milrinone lactate112
Bumetanide142
Vinorelbine12
Plerixafor113
Phytonadione131
Diazepam151
Metoprolol tartrate146
Argatroban112
Orphenadrine citrate118

Dosage forms

Dosage formProductsShare
Injection, solution11353.1%
Injection, powder, lyophilized, for solution4621.6%
Injection, powder, for solution2411.3%
Injection146.6%
Solution/ drops31.4%
Injection, suspension31.4%
Injection, emulsion20.9%
Solution20.9%
Solution, gel forming / drops20.9%
Injection, suspension, liposomal10.5%
Kit10.5%
Injection, solution, concentrate10.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Zyogreen25021-841Injection, solutionNew drug applications (NDA)July 16, 2026
Sugammadex25021-619Injection, solutionGeneric drugs (ANDA)July 1, 2026
Bludigo25021-840InjectionNew drug applications (NDA)April 15, 2026
Fulvestrant25021-471Injection, solutionGeneric drugs (ANDA)April 15, 2026
Doxorubicin Hydrochloride Liposome25021-263Injection, suspension, liposomalGeneric drugs (ANDA)March 1, 2026
Triamcinolone Acetonide25021-054Injection, suspensionGeneric drugs (ANDA)March 1, 2026
Diazepam25021-618Injection, solutionGeneric drugs (ANDA)February 15, 2026
Phytonadione25021-505Injection, emulsionGeneric drugs (ANDA)February 1, 2026
Acetazolamide25021-839Injection, powder, for solutionGeneric drugs (ANDA)January 15, 2026
Ertapenem25021-199Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)January 15, 2026
Timolol Maleate25021-009Solution, gel forming / dropsGeneric drugs (ANDA)January 15, 2026
Timolol Maleate25021-008Solution, gel forming / dropsGeneric drugs (ANDA)January 15, 2026
Dorzolamide Hydrochloride25021-006Solution/ dropsGeneric drugs (ANDA)January 15, 2026
Nicardipine Hydrochloride25021-333Injection, solutionGeneric drugs (ANDA)January 1, 2026
Carboprost Tromethamine25021-477Injection, solutionGeneric drugs (ANDA)December 1, 2025
Meropenem25021-161Injection, powder, for solutionGeneric drugs (ANDA)November 1, 2025
Meropenem25021-160Injection, powder, for solutionGeneric drugs (ANDA)November 1, 2025
Famotidine25021-756Injection, solutionNew drug applications (NDA)October 15, 2025
Famotidine25021-755Injection, solutionNew drug applications (NDA)October 15, 2025
Tranexamic Acid25021-415Injection, solutionGeneric drugs (ANDA)October 15, 2025
Methocarbamol25021-689Injection, solutionGeneric drugs (ANDA)October 1, 2025
Polymyxin B25021-196Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)October 1, 2025
Calcitonin Salmon25021-473Injection, solutionGeneric drugs (ANDA)September 15, 2025
Ertapenem25021-199Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 15, 2025
Azithromycin25021-180Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)August 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.